Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 11 studies | 29% ± 12% | |
peripheral blood | 10 studies | 26% ± 8% | |
kidney | 9 studies | 28% ± 8% | |
intestine | 8 studies | 32% ± 12% | |
liver | 5 studies | 31% ± 17% | |
lymph node | 5 studies | 26% ± 11% | |
pancreas | 4 studies | 37% ± 14% | |
bone marrow | 4 studies | 20% ± 2% | |
uterus | 4 studies | 30% ± 17% | |
breast | 4 studies | 24% ± 3% | |
brain | 4 studies | 22% ± 3% | |
eye | 3 studies | 26% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3245.52 | 1445 / 1445 | 100% | 41.62 | 183 / 183 |
skin | 100% | 3874.61 | 1809 / 1809 | 100% | 82.97 | 471 / 472 |
uterus | 100% | 2818.81 | 170 / 170 | 100% | 53.45 | 458 / 459 |
ovary | 100% | 2513.02 | 180 / 180 | 100% | 53.58 | 429 / 430 |
intestine | 100% | 3756.78 | 966 / 966 | 100% | 88.39 | 525 / 527 |
brain | 100% | 2079.61 | 2629 / 2642 | 100% | 43.55 | 704 / 705 |
stomach | 100% | 2808.89 | 359 / 359 | 99% | 75.79 | 284 / 286 |
thymus | 100% | 2758.88 | 653 / 653 | 99% | 39.86 | 600 / 605 |
lung | 100% | 2675.72 | 577 / 578 | 99% | 49.10 | 1147 / 1155 |
bladder | 100% | 3246.29 | 21 / 21 | 99% | 66.51 | 499 / 504 |
breast | 100% | 3529.20 | 459 / 459 | 99% | 58.60 | 1106 / 1118 |
pancreas | 99% | 1569.82 | 326 / 328 | 99% | 40.18 | 177 / 178 |
liver | 100% | 2298.45 | 225 / 226 | 99% | 40.59 | 403 / 406 |
prostate | 100% | 2735.20 | 245 / 245 | 99% | 42.63 | 496 / 502 |
kidney | 100% | 4794.52 | 89 / 89 | 99% | 45.22 | 889 / 901 |
adrenal gland | 100% | 3843.15 | 258 / 258 | 93% | 28.76 | 213 / 230 |
adipose | 100% | 3207.68 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 62.77 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 56.93 | 29 / 29 |
muscle | 100% | 3479.24 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2431.43 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 42.62 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 22.24 | 1 / 1 |
blood vessel | 100% | 2583.90 | 1333 / 1335 | 0% | 0 | 0 / 0 |
heart | 97% | 3995.74 | 836 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 89% | 2490.56 | 824 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0042177 | Biological process | negative regulation of protein catabolic process |
GO_0023035 | Biological process | CD40 signaling pathway |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_1901224 | Biological process | positive regulation of non-canonical NF-kappaB signal transduction |
GO_0002639 | Biological process | positive regulation of immunoglobulin production |
GO_0045917 | Biological process | positive regulation of complement activation |
GO_0001649 | Biological process | osteoblast differentiation |
GO_0007165 | Biological process | signal transduction |
GO_0048661 | Biological process | positive regulation of smooth muscle cell proliferation |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0070373 | Biological process | negative regulation of ERK1 and ERK2 cascade |
GO_0050847 | Biological process | progesterone receptor signaling pathway |
GO_2000323 | Biological process | negative regulation of glucocorticoid receptor signaling pathway |
GO_0010944 | Biological process | negative regulation of transcription by competitive promoter binding |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0044830 | Biological process | modulation by host of viral RNA genome replication |
GO_0043525 | Biological process | positive regulation of neuron apoptotic process |
GO_0045745 | Biological process | positive regulation of G protein-coupled receptor signaling pathway |
GO_0046718 | Biological process | symbiont entry into host cell |
GO_0071897 | Biological process | DNA biosynthetic process |
GO_0007005 | Biological process | mitochondrion organization |
GO_0042981 | Biological process | regulation of apoptotic process |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0050821 | Biological process | protein stabilization |
GO_0042113 | Biological process | B cell activation |
GO_0039529 | Biological process | RIG-I signaling pathway |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0060766 | Biological process | negative regulation of androgen receptor signaling pathway |
GO_0051897 | Biological process | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0040029 | Biological process | epigenetic regulation of gene expression |
GO_0070374 | Biological process | positive regulation of ERK1 and ERK2 cascade |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_1990051 | Biological process | activation of protein kinase C activity |
GO_0032740 | Biological process | positive regulation of interleukin-17 production |
GO_0072538 | Biological process | T-helper 17 type immune response |
GO_0071354 | Biological process | cellular response to interleukin-6 |
GO_0140374 | Biological process | antiviral innate immune response |
GO_0030308 | Biological process | negative regulation of cell growth |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0005769 | Cellular component | early endosome |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0009986 | Cellular component | cell surface |
GO_0035632 | Cellular component | mitochondrial prohibitin complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0019899 | Molecular function | enzyme binding |
GO_0001850 | Molecular function | complement component C3a binding |
GO_0031871 | Molecular function | proteinase activated receptor binding |
GO_0003714 | Molecular function | transcription corepressor activity |
GO_0042826 | Molecular function | histone deacetylase binding |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0001851 | Molecular function | complement component C3b binding |
GO_0005515 | Molecular function | protein binding |
Gene name | PHB1 |
Protein name | Prohibitin 1 Prohibitin |
Synonyms | PHB hCG_29613 |
Description | FUNCTION: Protein with pleiotropic attributes mediated in a cell-compartment- and tissue-specific manner, which include the plasma membrane-associated cell signaling functions, mitochondrial chaperone, and transcriptional co-regulator of transcription factors in the nucleus . Plays a role in adipose tissue and glucose homeostasis in a sex-specific manner (By similarity). Contributes to pulmonary vascular remodeling by accelerating proliferation of pulmonary arterial smooth muscle cells (By similarity). .; FUNCTION: In the mitochondria, together with PHB2, forms large ring complexes (prohibitin complexes) in the inner mitochondrial membrane (IMM) and functions as a chaperone protein that stabilizes mitochondrial respiratory enzymes and maintains mitochondrial integrity in the IMM, which is required for mitochondrial morphogenesis, neuronal survival, and normal lifespan (Probable). The prohibitin complex, with DNAJC19, regulates cardiolipin remodeling and the protein turnover of OMA1 in a cardiolipin-binding manner (By similarity). Regulates mitochondrial respiration activity playing a role in cellular aging . The prohibitin complex plays a role of mitophagy receptor involved in targeting mitochondria for autophagic degradation . Involved in mitochondrial-mediated antiviral innate immunity, activates RIG-I-mediated signal transduction and production of IFNB1 and pro-inflammatory cytokine IL6 . .; FUNCTION: In the nucleus, acts as a transcription coregulator, enhances promoter binding by TP53, a transcription factor it activates, but reduces the promoter binding by E2F1, a transcription factor it represses . Interacts with STAT3 to affect IL17 secretion in T-helper Th17 cells . .; FUNCTION: In the plasma membrane, cooperates with CD86 to mediate CD86-signaling in B lymphocytes that regulates the level of IgG1 produced through the activation of distal signaling intermediates (By similarity). Upon CD40 engagement, required to activate NF-kappa-B signaling pathway via phospholipase C and protein kinase C activation (By similarity). . |
Accessions | C9JW96 ENST00000446735.6 E7ESE2 ENST00000512041.7 [P35232-1] ENST00000696365.1 [P35232-2] ENST00000504124.6 [P35232-1] ENST00000512041 ENST00000419140.7 [P35232-1] ENST00000511832.6 [P35232-1] ENST00000504124 E9PCW0 P35232 ENST00000614445.5 [P35232-1] C9JZ20 ENST00000300408.8 [P35232-1] Q6FHP5 ENST00000419140 ENST00000617874.5 [P35232-1] A8K401 |